Suppression of DMBA/croton oil-induced mouse skin tumor promotion by Ardisia crispa root hexane extract

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 665-669

  Roslida, A H ^a   Fezah, O ^a   Yeong, L T ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Ardisia crispa; Cancer chemoprevention; DMBA skin carcinogenesis; Tumor incidence burden

Indexed keywords

EID: 79958774102     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Agarwal R and Mukhtar H (1991). Cutaneous chemical carcinogenesis. In Mukhtar H (ed) Pharmacology of the Skin, CRC Press, Boca Raton, FL. 371-87.
2. Aggarwal BB (2004). Nuclear factor-kappaβ: the enemy within. Cancer Cell, 6, 203-8.
3. Ara G and Teicher BA (1996). Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. PLEFA, 54, 3-16.
4. Bariwal JB, Upadhyay KD, Manvar AT, et al (2008). 1,5-Benzothiazepine, a versatile pharmacophore: a review. Eur J Med Chem, 43, 2279-90.
5. Berenblum I (1941). The mechanism of cocarcinogenesis: a study of the significance of cocarcinogenic action and related phenomena. Cancer Res, 1, 807-14.
6. Boutwell RK (1974). The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol, 2, 419-43.
7. Boutwell RK (1964). Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res, 4, 207-50.
8. Burkill IH (1966). A Dictionary of the Economic Plants of the Malay Peninsula. Vol 1 (A-H), ministry of agriculture and cooperative, Kuala Lumpur. 218-23.
9. Butler MS (2005). Natural products to drugs: natural product compounds in clinical trials. Natural Product Rep, 22, 162-95.
10. Cancer Research UK (2008). Skin Cancer Overview. http://info.cancerresearchuk.org/healthyliving/sunsmart/skincancer/.
11. Chen J, Pipoly JJ (1996). Myrsinaceae. In 'Flora of China 15'. Science press and missouri botanical garden press, St Louis. 1-38.
12. Chung J, Han J, Hwang E, et al (2003). Dual mechanism of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB, 17, 1913-5.
13. Craig WJ (1997). Phytochemicals: guardians of our health. J Am Diet Assoc, 97, S199-204.
14. de Mejía EG, Ramírez-Mares MV, Arce-Popoca E, et al (2004). Inhibition of liver carcinogenesis in Wistar rats by consumption of an aqueous extract from leaves of Ardisia compressa. Food Chem Toxicol, 42, 509-16.
15. Deelman HT (1927). The part played by injury and repair in the development of cancer. Br Med J, 1, 872.
16. DiGiovanni J (1992). Multistage carcinogenesis in mouse skin. Pharmac Ther, 54, 63-128.
17. Duke JA and Ayensu ES (1985). Medicinal plants of China. Reference publications, Inc.
18. Flavin DF (1984). Toxicity, tumor promotion, and carcinogenesis in relation to excessive dosage. Regul Toxicol Pharm, 4, 372-9.
19. Girit IC, Jure-Kunkel M, McIntyre KW (2008). A structured light-based system for scanning subcutaneous tumors in laboratory animals. Comp Med, 58, 264-70.
20. Hong WK and Sporn MB (1997). Recent advances in chemoprevention of cancer. Science, 278, 1073-7.
21. Huang MT, Lysz T, Ferraro T, et al (1991). Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res, 51, 813-9.
22. Ito H, Miyake M, Nishitani E, et al (1999). Anti-tumor promoting activity of polyphenols from Cowania Mexicana and Colegyne ramosissima. Cancer Lett, 143, 5-13.
23. Jansakul C, Baumann H, Kenne L, Samuelsson G (1987). Ardisiacrispin A and B, two utero-contracting saponins from Ardisia crispa. Planta Medica, 53, 405-9.
24. Jansakul C (1995). Some pharmacological studies of ardisiacrispin B, an utero-contracting saponin, isolated from Ardisia crispa. J Sci Soc Thailand, 21, 11-26.
25. Kang YH, Kim WH, Park MK, et al (2001). Antimetastatic and antitumor effects of benzoquinonoid AC7-1 from Ardisia crispa. Int J Cancer, 93, 736-40.
26. Kellen JA (1999). Chemoprevention of cancer: an ongoing saga. In Vivo, 13, 423-6.
27. Kelloff GJ (2000). Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res, 78, 199-334.
28. Lau MF, Roslida AH, Sabrina S, et al (2009). Anti-inflammatory and anti-pyretic effects of hexane fraction of Ardisia crispa Thunb, D.C. Pharmacologyonline, 3, 29-39.
29. Lee SJ, Sung JH, Lee SJ, et al (1999). Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett, 144, 39-43.
30. Mann J (2002). Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer, 2, 143.
31. Marks R (1976). Epidermal growth control mechanism, hyperplasia, and tumor promotion in the skin. Cancer Res, 36, 1379-2643.
32. Muhammad Z and Mustafa AM (1994). Traditional Malay medicinal plants. Fajar Bakti, Kuala Lumpur, 39-41.
33. Newman DJ and Cragg GM (2005). The discovery of anticancer drugs from natural sources. In 'Natural Products: Drug Discovery and Therapeutic Medicine', Eds Zhang L and Demain AL. Humana Press, New Jersey pp129.
34. Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J Nat Prod, 66, 1022-37.
35. Nishino H, Yoshioka K, Iwashima A, et al (1986). Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Jpn J Cancer Res, 77, 33-8.
36. Nishino H, Murakoshi M, Mou XY, et al (2005). Cancer prevention by phytochemicals. Oncology, 69, 38-40.
37. Noor Rain A, Khozirah S, Mohd Ridzuan MAR, et al (2007). Antiplasmodial properties of some Malaysian medicinal plants. Tropical Biomedicine, 24, 29-35.
38. Ramawat KG (2007). Production of alkaloids. In 'Biotechnology: Secondary Metabolites, Plants and Microbes', Eds Ramawat KG and Merillon JM. Science Publishers, New Hampshire pp179.
39. Rao AV and Shen H (2002). Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress. Nutr Res, 22, 1125-31.
40. Roslida AH and Kim KH (2008). Anti-inflammatory and anti-hyperalgesic effects of Ardisia crispa Thunb. D.C. Pharmacognosy Magazine, 4, 262-8.
41. Russo GL (2007). Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol, 74, 533-44.
42. Schulte-Herman R, Timmermann-Trosiener I, Schupper J (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res, 43, 839-44.
43. Sengupta A, Ghosh S, Bhattacharjee S, et al (2004). Indian food ingredients and cancer prevention- an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pac J Cancer Prev, 5, 126-32.
44. Shankar R, Chakravarti B, Singh US, et al (2009). Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as apotential new class of anti-breast cancer agents. Bioorgan Med Chem, 17, 3847-56.
45. Soltis PS and Soltis DE (2001). Molecular systematics: assembling and using the tree of life. Taxon, 49, 451-7.
46. Sporn MB, Dunlop NM, Newton DL, et al (1976). Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc, 35, 1332-8.
47. Stewart BW, Kleihues P (2003). Cancer facts and figures 2004. IARC press, world cancer report, American cancer society.
48. World Health Organization. Ultraviolet radiation and the INTERSUN Programme. http://www.who.int/uv/faq/skincancer/en/index1.html.
49. World Health Organization. Cancer. http://www.who.int/topics/cancer/en/.